Field Trip Health has received conditional approval to list on the NASDAQ, symbol "FTRP".
Field Trip Health has received conditional approval to list on the NASDAQ, symbol "FTRP".
Psyched Wellness announces the largest extraction and shipment of its flagship nootropic (AME-1) to Asia.
Cybin announces a conditional listing on the NYSE American exchange.
Small Pharma is starting its DMT-based training program for psychedelic-assisted therapy with its Phase IIa clinical trial due to start immediately.
Novamind seeks to increase access for U.S. investors through its OTC application.
Mydecine files a new patent application in support of its MDMA-based psychedelic drug research.
Psytech Inc is becoming a wholly-owned subsidiary of Wesana Health for an acquisition price of CAD$21 million in an all-share transaction.
Red Light Holland announces that its iMicrodose Packs are now available in 30 storefronts and announces total sales of 350,000 grams of "magic truffles".
Cybin's latest patent application is in support of its proprietary digital therapeutics platform for mental health treatment.
Numinus receives Health Canada approval to move forward with MAPS in its clinical testing for PTSD.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now